Vir Biotechnology Presents New Data Evaluating the
– Data from two ongoing clinical trials in people living with chronic hepatitis B infection suggest the combination of an antiviral with an immunomodulator...
Source: globenewswire.com
Stay updated with breaking news from Marka Schmidt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Data from two ongoing clinical trials in people living with chronic hepatitis B infection suggest the combination of an antiviral with an immunomodulator...
– Data support the potential impact of VIR-2218 and VIR-3434 in addressing both HBV and HDV and underscore the Company’s confidence in its approach to a functional cure for HBV – SAN... | June 7, 2023
Acute gastroenteritis is common in the United States and can be spread by asymptomatic virus shedders, report researchers, who recommend hand hygiene and vaccination in order to reduce the spread.